Home » Newsletters » BioWorld

BioWorld

June 4, 1993

View Archived Issues

FDA SETS UP NEW SYSTEM TO REPORT ADVERSE REACTIONS

APPOINTMENTS AND ADVANCEMENTS

PACT WITH MMD WORTH $17.5M TO SEPRACOR

UNIVAX FILES PLA

PROCORDIA TO FOCUS ON BIOTECH

THREE-WAY PCR DISPUTE RESOLVED

GERON RAISES $10.7M IN VENTURE FINANCING

BAXTER DISTRIBUTES STEM-CELL SELECTION SYSTEM

RHONE BUYS 37% OF AIS FOR $113M

CENTORX ENTERS PHASE III FOR ANGINA

$20 MILLION ALPHA-BETA PRIVATE PLACEMENT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 18, 2025.
An early stage 85% remissions rate in AML drives Aptevo’s stock surge
BioWorld
An 85% remissions rate was found in updated results from Aptevo Therapeutics Inc.’s ongoing phase Ib/II Ranier study of mipletamig in one of the toughest blood...
BIO 2025: Makary lays out FDA’s path, launches pilot review program
BioWorld
On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation Organization’s International Convention, the...
Alphadesign: AI creating proteins from scratch
BioWorld Science
The Alphafold machine learning system for predicting a protein’s structure from its amino acid sequence has been adapted to make it possible to design de novo...